Back to News
Market Impact: 0.25
Pfizer Inc. Reports Third-Quarter 2026 Results and Raises Full-Year Guidance
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Pfizer reported third-quarter 2026 revenue of $16.6 billion, relatively flat year over year on an operational basis. Excluding Comirnaty and Paxlovid, revenue grew 7% operationally; the available article text provides no further results or outlook details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment
PFE0.10
More News
- Pfizer hikes full-year outlook, taps company veteran as new CFO
- Pfizer earnings analysis: questions answered and next catalysts
- Stocks making the biggest moves midday: Apple, Palantir, Nvidia, Coinbase, Bloom Energy & more
- Stocks making the biggest moves premarket: Pfizer, Apple, Palantir, Zebra Technologies & more
- Election Day Trading Splits the Benchmarks, With the Dow Lower and the Nasdaq Higher
- Stock Movers: PFR, AAPL, BE (Podcast)